Skip main navigation

Anti-coagulant

video

Antocoagulants work via different mechanisms, thrombolytic, antiplatelet or plasminogen activator r-hirudin and drotrecogin are both direct thrombin inhibitors. Tissue plasminogen activator (tPA) is involved in the breakdown of blood clots. All products are produced by recombinant technology nowadays.

Two historical anticoagulants are introduced: r-hirudin, derived from yeast cells and indicated for heparin induced thrombocytopenia (HIT). Drotrecogin, a r-activated protein C indicated for sepsis (withdrawn 2011) Three TPAs used today are Alteplase, Reteplase, and Tenecteplase, of which Tenecteplase is a prolonged release formulation. All of them are indicated for rescue from myocardial infarction or ischemic attack.

This article is from the free online

Pharmacotherapy: Understanding Biotechnology Products

Created by
FutureLearn - Learning For Life

Reach your personal and professional goals

Unlock access to hundreds of expert online courses and degrees from top universities and educators to gain accredited qualifications and professional CV-building certificates.

Join over 18 million learners to launch, switch or build upon your career, all at your own pace, across a wide range of topic areas.

Start Learning now